Donald Nicholson
Vermögen: 1 Mio $ am 31.08.2026
Vermögen: 1 Mio $ am 31.08.2026
Dr. Donald W.
Nicholson is an Independent Chairman at Muna Therapeutics ApS, an Executive Chairman at NodThera Ltd., an Executive Chairman at Disc Medicine Opco, Inc., an Executive Chairman at Disc Medicine, Inc., an Advisor at Atlas Venture Advisors, Inc., a Chief Executive Officer at Nimbus Apollo, Inc. and a Vice President at Merck Frost Centre For Therapeutic Research, Inc. He is on the Board of Directors at Matchpoint Therapeutics, Inc. Dr. Nicholson was previously employed as an Executive Chairman by Gemini Therapeutics, Inc., a Chairman by Jnana Therapeutics, Inc., an Executive Chairman by Generation Bio Co., an Independent Director by Kymera Therapeutics, Inc., a Chief Executive Officer & Director by Nimbus Therapeutics LLC, and a VP & Discovery Head-Respiratory Franchise by Merck & Co., Inc. He received his undergraduate degree from the University of Western Ontario and a doctorate degree from the University of Western Ontario.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
DISC MEDICINE, INC. 0,04 % | 18.06.2026 | 15 332 ( 0,04 % ) | 1 Mio $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| DISC MEDICINE, INC. | Vorsitzender | 01.04.2019 |
Nimbus Apollo, Inc.
Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery research services | Vorstandsvorsitzender | - |
NodThera Ltd.
NodThera Ltd. BiotechnologyHealth Technology Operates biotechnology company which discovers and develops new treatments for diseases driven by chronic inflammation | Vorsitzender | 10.04.2019 |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies for hematologic diseases | Vorsitzender | 01.04.2019 |
Merck Frost Centre For Therapeutic Research, Inc. | Corporate Officer/Principal | - |
Muna Therapeutics ApS
Muna Therapeutics ApS BiotechnologyHealth Technology Engages in discovering and developing of therapies that slow and stop devastating neurodegenerative, alzheimer’s & parkinson’s diseases | Vorsitzender | 13.09.2021 |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Berater | - |
Matchpoint Therapeutics, Inc.
Matchpoint Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company harnessing the power of covalency to discover precision covalent medicines | Direktor/Vorstandsmitglied | 01.11.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
| GENERATION BIO CO. | Vorsitzender | 06.02.2026 |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░ | ░░░░░░░░░░░░ | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 15 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Nimbus Therapeutics LLC
Nimbus Therapeutics LLC BiotechnologyHealth Technology Operates as a clinical stage biotech company that develops molecule medicines for diseases like cancer, immune disorders and metabolic conditions | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
University of Western Ontario
University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nimbus Apollo, Inc.
Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery research services | Health Technology |
Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Operates as a chemo proteomics platform to develop small molecule medicines | Health Technology |
Generation Bio Co.
Generation Bio Co. Pharmaceuticals: MajorHealth Technology Develops and commercializes genetic medicines | Health Technology |
NodThera Ltd.
NodThera Ltd. BiotechnologyHealth Technology Operates biotechnology company which discovers and develops new treatments for diseases driven by chronic inflammation | Health Technology |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies for hematologic diseases | Commercial Services |
Muna Therapeutics ApS
Muna Therapeutics ApS BiotechnologyHealth Technology Engages in discovering and developing of therapies that slow and stop devastating neurodegenerative, alzheimer’s & parkinson’s diseases | Health Technology |
Gemini Therapeutics, Inc.
Gemini Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for dry age-related macular degeneration and associated rare genetic diseases | Health Technology |
Merck Frost Centre For Therapeutic Research, Inc. | |
Matchpoint Therapeutics, Inc.
Matchpoint Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company harnessing the power of covalency to discover precision covalent medicines | Health Technology |
Disc Medicine, Inc.
Disc Medicine, Inc. BiotechnologyHealth Technology Develops therapies addressing red blood cell production in hematologic diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen